The hydrolytic activity of bovine adrenal medullary plasma membranes towards diadenosine polyphosphates is due to alkaline phosphodiesterase-I  by Gasmi, Lakhdar et al.
The hydrolytic activity of bovine adrenal medullary plasma membranes
towards diadenosine polyphosphates is due to alkaline
phosphodiesterase-I
Lakhdar Gasmi, Jared L. Cartwright, Alexander G. McLennan *
Cellular Regulation and Signalling Group, School of Biological Sciences, Life Sciences Building, University of Liverpool, Crown St,
Liverpool L69 7ZB, UK
Received 9 June 1998; revised 5 August 1998; accepted 7 August 1998
Abstract
A hydrolase activity directed against diadenosine 5P,5QP-P1,P4-tetraphosphate (Ap4A) has been solubilised and partially
purified from the plasma membrane fraction of bovine adrenal medullary chromaffin tissue in order to determine its
relationship to alkaline phosphodiesterase-I/nucleotide pyrophosphatase (PDase-I, EC 3.1.4.1). Activity with the specific
dinucleoside tetraphosphatase (EC 3.6.1.17) substrate Ap4A and with the non-specific PDase-I substrate thymidine
5P-monophosphate p-nitrophenyl ester had Km and Vmax values of 2.0 WM and 600 pmol/min/mg protein and 0.2 mM and
26 nmol/min/mg protein respectively and co-chromatographed upon gel filtration and ion-exchange chromatography.
Activity with the fluorescent substrates etheno-Ap4A and 4-methylumbelliferyl phenylphosphonate co-electrophoresed on
native polyacrylamide gels. No activity was detected which exclusively hydrolysed Ap4A. Immunoblotting of the most
purified fraction with an antibody against mouse PC-1, one of the major PDase-I family members, detected bands of 240,
120 and 62 kDa corresponding to PC-1 dimer, monomer and proteolytic fragment. Therefore, the activity previously
described as bovine adrenal chromaffin cell ecto(diadenosine polyphosphate hydrolase) (ecto-ApnAase) is a PDase-I,
probably bovine PC-1. ß 1998 Elsevier Science B.V. All rights reserved.
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1. Introduction
The monoamine storage granules of a number of
secretory cell types are known to contain various
dinucleoside polyphosphates in addition to ATP
and other mononucleotides. For example, diadeno-
sine 5P,5QP-P1,P4-tetraphosphate (Ap4A), diadenosine
5P,5QP-P1,P5-pentaphosphate (Ap5A) and diadenosine
5P,5QP-P1,P6-hexaphosphate (Ap6A) are found in
chroma⁄n cell granules [1,2] and Ap4A and Ap5A
in the synaptic vesicles of rat brain and the Torpedo
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Abbreviations: ApnA, diadenosine polyphosphate; Ap3A, dia-
denosine 5P,5QP-P1,P3-triphosphate; Ap4A, diadenosine 5P,5QP-
P1,P4-tetraphosphate; Ap5A, diadenosine 5P,5QP-P1,P5-penta-
phosphate; Ap6A, diadenosine 5P,5QP-P1,P6-hexaphosphate;
p4A, adenosine 5P-tetraphosphate; OAp4OA, di(N6-ethenoadeno-
sine) 5P,5QP-P1,P4-tetraphosphate; TpNP, thymidine 5P-mono-
phosphate p-nitrophenyl ester; 4-MupPh, 4-methylumbelliferyl
phenylphosphonate; ecto-ApnAase, ecto(diadenosine polyphos-
phate hydrolase); PDase-I, alkaline phosphodiesterase I; SDS-
PAGE, SDS polyacrylamide gel electrophoresis
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electric organ [3,4], while blood platelet dense gran-
ules contain a wide variety of adenine- and guanine-
containing dinucleotides in addition to larger quanti-
ties of Ap4A and diadenosine 5P,5QP-P1,P3-triphos-
phate (Ap3A) [5,6]. These compounds have been pro-
posed to act as extracellular signalling molecules
through their interaction with known P2 receptor
subtypes and possibly unique dinucleotide receptors
[7^9] and so can initiate or modulate a number of
biological processes, including vasoconstriction and
vasodilation [10,11], platelet aggregation [9,12], neu-
rotransmission [13], neutrophil priming and apopto-
sis [14], and cell proliferation [15].
Understanding the physiological function of the
dinucleotides requires a knowledge of their metabo-
lism. The intracellular, cytoplasmic levels of these
compounds are regulated by highly speci¢c hydro-
lases, e.g. dinucleoside triphosphatase (EC 3.6.1.29)
[16,17] and dinucleoside tetraphosphatase (EC
3.6.1.17) [16,18] hydrolases in mammalian cells and
a hydrolase active only on higher polyphosphates
such as Ap5A and Ap6A found in yeast [19]. In ad-
dition, alkaline phosphodiesterase I (PDase-I, EC
3.1.4.1) is known to degrade these compounds and
a clear distinction between this activity and the spe-
ci¢c ApnA hydrolases from rat liver has been drawn
[20]. Extracellularly, both soluble and cell surface
enzymes could potentially be involved. A family of
soluble enzymes has been described in plasma which
can degrade Ap3A and Ap4A [21]. These appear to
be isozymes of the soluble forms of PDase-I [22].
Ectoenzyme activities described as ecto(diadenosine
polyphosphate hydrolases) (ecto-ApnAases) have
also been detected in a variety of cells and tissues
including porcine and bovine aortic endothelial cells
[23,24], bovine chroma⁄n cells and puri¢ed plasma
membranes [25], bovine adrenomedullary vascular
endothelial cells [26] and the presynaptic plasma
membrane of the Torpedo electric organ [27]. How-
ever, the molecular nature and substrate speci¢city of
those membrane-bound hydrolases which degrade
ApnA have not been determined. Since these enzymes
may play a crucial role in regulating extracellular
diadenosine polyphosphate levels and their subse-
quent signalling functions, it is important that they
are more fully characterised. Here, we provide evi-
dence that hydrolytic activity on ApnA present in
puri¢ed plasma membranes from bovine adrenal
medulla corresponds to an alkaline PDase-I/nucleo-
tide pyrophosphatase, probably the glycoprotein
PC-1.
2. Materials and methods
2.1. Materials
Frozen bovine adrenal glands were obtained from
First Link (UK). Thymidine 5P-monophosphate p-ni-
trophenyl ester (TpNP) and dinucleoside polyphos-
phates were from Sigma. [3H]Ap4A (4.3 Ci/mmol)
and the enhanced chemiluminescence (ECL) detec-
tion kit were from Amersham International. Alkaline
phosphatase and snake venom phosphodiesterase
were from Boehringer. Di(N6-ethenoadenosine)
5P,5QP-P1,P4-tetraphosphate (OAp4OA) and 4-methyl-
umbelliferyl phenylphosphonate (4-MupPh) were
synthesised as described [28,29]. The 4H4 monoclo-
nal anti-PC-1 antibody [30] was the generous gift of
J.W. Goding.
2.2. Solubilisation of puri¢ed bovine adrenal medulla
plasma membrane
Adrenal medulla plasma membrane-enriched frac-
tions were prepared as described [31] Brie£y, the me-
dulla was dissected from the glands, cut into small
pieces and homogenised in 10 mM Tris-HCl, pH 7.2,
containing 0.32 M sucrose and 5 mM phenylmethyl
sulphonyl £uoride. The homogenate was centrifuged
at 800Ug for 10 min, the supernatant collected and
recentrifuged at 10 000Ug for 30 min. The superna-
tant was discarded and the pellet resuspended in
0.32 M sucrose containing 10 mM Tris-HCl, pH
7.2, and placed over a discontinuous sucrose gradient
comprising layers of 0.95, 1.34 and 1.6 M sucrose in
10 mM Tris-HCl, pH 7.2. The plasma membrane
fractions were collected at the 0.32^0.95 M sucrose
interface, washed and stored at 370‡C before solu-
bilisation. Membranes at a protein concentration of
1.5 mg/ml were extracted overnight at 4‡C with 0.5%
Triton X-100, 20 mM octyl-L-D-glucopyranoside,
0.3 M NaCl, 0.025 M sodium phosphate bu¡er, pH
7.4, 0.02% NaN3 and protease inhibitors [32]. The
mixture was centrifuged at 150 000Ug for 60 min
at 4‡C to remove insoluble material. The supernatant
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was recovered and stored at 4‡C until further analy-
sis.
2.3. In gel £uorescence assays
Solubilised total plasma membrane proteins were
separated by electrophoresis in two identical 10%
polyacrylamide gels under non-denaturing and non-
reducing conditions by standard procedures. The gels
were washed brie£y in 50 mM Tris-HCl at pH 8.5
then incubated at 37‡C for 45 min in 50 mM Tris-
HCl, pH 8.5, 5 mM Mg-acetate containing either
50 WM OAp4OA or 0.5 mM 4-MupPh. The gels
were then placed on a UV transilluminator to visual-
ise speci¢c (OAp4OA) and non-speci¢c (4-MupPh)
catabolic activities.
2.4. Other assays
Hydrolytic activity directed towards [3H]Ap4A in
fractions derived from solubilised plasma membranes
was measured radiometrically as previously described
[33]. Non-speci¢c PDase-I activity was assayed col-
orimetrically by measuring the release of p-nitrophe-
nol from TpNP. The assay mixture contained 20 mM
Tris-HCl, pH 9.0, 1 mM Mg-acetate and 0.2 mM
TpNP in a total volume of 100 Wl. After incubation
for the desired times at 37‡C, samples were removed
and the absorbance at 405 nm measured. An absorp-
tion coe⁄cient of 18.32 mM31 cm31 was used for
calculations [34]. Protein concentrations were deter-
mined by the Coomassie blue binding method [35].
3. Results
3.1. Measurement of hydrolytic activities in bovine
adrenal medullary plasma membranes
The diadenosine polyphosphate (ApnA) hydrolytic
activity previously described in bovine adrenal chro-
ma⁄n cells and plasma membranes breaks down all
ApnA tested yielding AMP and Apnÿ1 [25]. An
added divalent ion was not essential for activity
though it was stimulated by Mg2, Mn2 and Ca2
ions. These properties are consistent with alkaline
PDase-I/nucleotide pyrophosphatase, an activity
which is widespread in many tissues [34] and which
is known to degrade dinucleoside polyphosphates ef-
¢ciently [16]. In contrast, the speci¢c cytoplasmic
Ap3A and Ap4A hydrolases have a much more re-
stricted substrate speci¢city and are divalent ion-de-
pendent [16]. In order to determine whether PDase-I
could account for all or part of the observed ApnA
hydrolysis, puri¢ed plasma membranes were isolated
from bovine adrenal medulla and assayed for Ap4A
hydrolase activity with [3H]Ap4A and for PDase-I
with TpNP. Ap4A hydrolase activity was detected
with a Km of 2.0 WM and Vmax of 600 pmol/min/
mg protein. These ¢gures compare to the previously
published values of 2.4 WM and 746 pmol/min/mg
protein, respectively, for cultured chroma⁄n cell
plasma membranes [25] and so would appear to rep-
resent the same activity. This is important, since
chroma⁄n cells only represent about 50% of the
mass of the adrenal medulla [36], although they
probably yield s 90% of the material isolated after
removal of connective and vascular tissue at the ¢rst
centrifugation step (see Section 2). With TpNP as
substrate, the Km was 0.2 mM and Vmax 26 nmol/
Fig. 1. In-gel £uorescence assay for the detection of Ap4A hy-
drolase (OAp4OA) and phosphodiesterase-I (4-MupPh) activities
in puri¢ed plasma membranes prepared from bovine adrenal
medulla. Native polyacrylamide gels were prepared and run
under non-reducing conditions as described in Section 2. Gels
were incubated with appropriate substrates as indicated, visual-
ized by UV transillumination and then aligned.
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min/mg. Hence, alkaline PDase-I activity is clearly
present in this membrane fraction. According to
the Vmax/Km ratios, Ap4A is hydrolysed approxi-
mately 3-fold more e⁄ciently than TpNP. Hydrolysis
of both [3H]Ap4A and TpNP was inhibited by ad-
enosine 5P-tetraphosphate with Ki values of 20 and
25 WM respectively, but was resistant to NaF, again
con¢rming the similarity of this activity to that iso-
lated from cultured chroma⁄n cells [25] and distin-
guishing it from the £uoride-sensitive adrenal vascu-
lar endothelial cell activity [26].
In order to determine whether the hydrolysis of
ApnA and TpNP was due to the same or di¡erent
enzyme species, total plasma membrane proteins
were separated by PAGE under non-reducing and
non-denaturing conditions and subjected to an in-
gel assay for speci¢c Ap4A hydrolase and non-spe-
ci¢c PDase-I using the £uorescent substrates OAp4OA
and 4-MupPh, respectively. In both cases, the prod-
ucts of hydrolysis show greatly increased £uorescence
compared to the substrates and so hydrolytic activ-
ities can be readily visualised in the gels. Fig. 1 shows
a clear £uorescent band of similar mobility in iden-
tical gels incubated in each substrate. A second more
di¡use band was also observed at the top of both
gels and probably represents aggregated membrane
proteins. No bands were observed with either sub-
strate alone, suggesting that all the Ap4A hydrolase
activity can be accounted for by PDase-I. Further-
more, the activities measured in the same whole
membrane fractions with both substrates had very
similar heat inactivation pro¢les, with 50% of both
activities lost after 10 min incubation at 60‡C (not
shown).
3.2. Partial puri¢cation of Ap4A hydrolase activity
from adrenal medulla plasma membranes
Further evidence that PDase-I and the activity
against Ap4A reside on the same protein came
from attempts to separate them by chromatography
of solubilised membrane proteins. When subjected to
high performance gel ¢ltration on Superdex-200,
both activities co-eluted as a single sharp peak
shortly after the void volume (Fig. 2). Based on cal-
ibration with known molecular weight markers, the
apparent molecular weight of these activities was
200^230 kDa, a size consistent with PDase-I family
members [30]. Active fractions were pooled and a
sample separated by ion-exchange chromatography
Fig. 3. Detection of phosphodiesterase-I and hydrolytic activity
on Ap4A after ion-exchange chromatography of partially puri-
¢ed adrenal medulla plasma membrane proteins. A 1 ml sample
of the pooled active fractions isolated after gel ¢ltration was
applied to a 1 ml Mono-Q anion-exchange column equilibrated
in 50 mM Tris-HCl, pH 8.5, containing 0.2% Triton X-100.
The column was eluted with a 15 ml linear gradient of 0-0.5 M
NaCl at a £ow rate of 1 ml/min. Fractions (1 ml) were assayed
for Ap4A hydrolase (a) and phosphodiesterase-I (b) activities
as described in Section 2.
Fig. 2. Detection of phosphodiesterase-I and hydrolytic activity
on Ap4A after gel ¢ltration of solubilized adrenal medulla plas-
ma membranes. Solubilized membrane proteins (2 ml) were ap-
plied to a HiLoad 16/60 Superdex-200 column equilibrated in
50 mM Tris-HCl, pH 7.5, 0.1 M NaCl, 5% glycerol, 0.5% Tri-
ton X-100 at a £ow rate of 1 ml/min. Fractions (2 ml) were as-
sayed for Ap4A hydrolase (a) and phosphodiesterase-I (b) ac-
tivities as described in Section 2. The column was calibrated
with the following molecular weight markers (n) : apoferritin
(443 kDa), alcohol dehydrogenase (150 kDa), bovine serum al-
bumin (66 kDa), carbonic anhydrase (29 kDa) and cytochrome
c (12.4 kDa).
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on a Mono-Q column. Again, activities with both
substrates co-eluted. Although there was some evi-
dence of charge heterogeneity or minor activities
from non-chroma⁄n cell types, it is important to
note that no fractions displayed signi¢cant preferen-
tial hydrolysis of Ap4A (Fig. 3).
3.3. Puri¢ed ecto-ApnAse fraction contains the
phosphodiesterase PC-1
A sample of the peak Mono-Q fraction was sepa-
rated by PAGE under both reducing and non-reduc-
ing conditions, transferred to nitrocellulose and
probed with a monoclonal antibody (4H4), which
recognizes the conserved EF-hand homology region
of PC-1, one of the three members of the ecto-
PDase-I family characterised so far. This antibody
recognises other mammalian homologues of PC-1
[30]. In the reduced sample, three bands were visible
with approximate molecular masses of 240, 120 and
62 kDa (Fig. 4, lane R). In the non-reduced sample,
only one band of approximately 260 kDa was de-
tected (Fig. 4, lane NR). Mouse and human PC-1
are, respectively, 240 and 260 kDa dimers, held to-
gether by disulphide linkages, with a considerable
amount of dimer persisting even under reducing con-
ditions, as observed here [34]. The apparent smaller
size of the dimer observed under reducing conditions
may re£ect a conformational change induced by the
e¡ect of mercaptoethanol on the cysteine-rich region
of PC-1 [30] or may simply have resulted from ref-
ormation of the dimer after entry of the reduced
sample into the non-reducing gel. The 62 kDa species
may be a proteolytic product of PC-1 released under
reducing conditions; the 127 kDa porcine chondro-
cyte PDase-1 readily generates a major 61 kDa pro-
teolytic fragment [37]. These results clearly show that
the partially puri¢ed ecto-ApnAase fraction contains
bovine PC-1. Since all our other data suggest that a
single PDase-1 is responsible for the bulk of the hy-
drolytic activity towards Ap4A, it seems most likely
that the activity previously described as ecto-
ApnAase from bovine adrenal medullary chroma⁄n
cells is bovine PC-1.
4. Discussion
The ecto-phosphodiesterase family comprises at
least three distinct, but related, enzymes with alkaline
phosphodiesterase I and nucleotide pyrophosphatase
activity and with a widespread but non-identical dis-
tribution. These are PC-1, PD-1K (autotaxin) and
PD-1L (B10) [30]. These enzymes have a broad sub-
strate range and hydrolyse the phosphodiester bonds
of nucleic acids and nucleotides (e.g. cAMP) and the
pyrophosphate linkages of nucleoside polyphos-
phates (e.g. ATP, ADP), nucleotide sugars (e.g.
UDP-galactose), and dinucleoside polyphosphates
(e.g. Ap3A, Ap4A). Their precise functions in vivo
are not yet fully understood. On the one hand,
they may simply act to salvage extracellular nucleo-
tides and nucleotide-sugars by converting them to
transportable nucleosides or to protect cells from
potential transformation by extracellular DNA or
Fig. 4. Immunodetection of the PC-1 phosphodiesterase in puri-
¢ed bovine adrenal medulla ecto-ApnAase fraction. The peak
fraction eluting from the Mono-Q column was concentrated by
ultra-¢ltration and samples prepared under reducing (R) and
non-reducing (NR) conditions and separated by SDS-PAGE in
the absence of reducing agent. The separated proteins were
then transferred to nitrocellulose and the membranes blocked
overnight at 4‡C with 3% fat-free powdered milk in PBS con-
taining 0.2% Tween-20. The blots were then probed with the
4H4 monoclonal anti-PC-1 antibody followed by horseradish
peroxidase-conjugated sheep anti-mouse second antibody. The
membrane was developed by enhanced chemiluminescence
(ECL).
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RNA. On the other hand, they may serve to termi-
nate the signalling functions of nucleotides, such as
Ap4A, by destroying them or to generate physiolog-
ically active adenosine locally. These functions may
not be mutually exclusive and their relative impor-
tance may be dictated by the tissue distribution of
the PDase and by the availability of substrates and
activating or inhibitory ions. As far as dinucleoside
polyphosphates are concerned, the chroma⁄n cell
PDase-I may be important in controlling the modu-
latory e¡ect of these compounds on catecholamine
release from these cells [38]. Any salvage of the re-
sulting mononucleotides would be a secondary func-
tion. In contrast, salvage of circulating nucleotides
may be a more important function for the adreno-
medullary vascular endothelial cell ecto-ApnAase (see
below) [26].
Although our results implicate PC-1 as the most
likely candidate for the hydrolytic activity on ApnA
present on adrenal chroma⁄n cells, some published
data are not entirely consistent with this view. Mouse
PC-1 is a type II membrane protein which is an-
chored in the membrane by a 21-amino acid trans-
membrane sequence [39]. On the basis of sequence
comparisons, PD-1K and PD-1L are predicted to
have a similar topology [40,41]. It has been suggested
that an ecto-ApnAase activity of cultured bovine chro-
ma⁄n cells is attached via a glycosyl phosphatidyl-
inositol anchor since activity is reduced by 50% after
incubation with phosphatidylinositol-speci¢c phos-
pholipase C [25]. However, concomitant release of
activity in a soluble form was not shown. Further-
more, PDase-I activity in some, but not all, mamma-
lian tissues can be partially released by this treatment
[42,43]. The reasons for this discrepancy have not
been explained, but heterogeneity of PDase-I and
ecto-ApnAase activities within a single tissue and
even a single cell type is clearly indicated, as has
recently been veri¢ed in rat hepatocytes which ex-
press PC-1 on the basolateral membrane and PD-
1L on the apical membrane [44]. Thus, it is essential
that future studies of ecto-ApnAase activity should
recognise the fact that whole cell and membrane
preparations are likely to contain more than one hy-
drolase active against dinucleoside polyphosphates.
The results reported here suggest that only a single
major PDase-I/ecto-ApnAase is present in bovine
adrenal chroma⁄n cells, although it is possible that
unseparated PDase-I isozymes are present in the ¢nal
preparation. What is clear is that there is no ecto-
ApnAase activity present that cannot use the non-
speci¢c PDase-I substrate 4-MupPh.
It remains to be determined whether the hydrolytic
activities on ApnA present on the outer surface of
other cells and tissues are also due to alkaline
PDase-I. It has been proposed that ecto-ApnAases
fall into two broad groups: a neural type, exempli-
¢ed by the adrenal chroma⁄n and Torpedo presyn-
aptic membrane enzymes; and an endothelial cell
type [26]. Thus, the activity measured on cultured
adrenomedullary vascular endothelial cells is inhib-
ited by Ca2 and F3 ions and has a very low Km for
Ap4A of 0.4 WM, while the chroma⁄n cell enzyme is
activated by Ca2, is insensitive to F3 and has a
higher Km for Ap4A of 2.4 WM [26]. The Torpedo
enzyme is similar to the chroma⁄n cell enzyme ex-
cept that it is moderately sensitive to F3 [27]. Until
the various known PDase-I family members have
been fully characterised with dinucleoside polyphos-
phates as substrates, one can only speculate on the
precise relationship between them and these other
ecto-ApnAases. However, preliminary immunoblot-
ting experiments with isolated Torpedo presynaptic
membranes have revealed a number of species that
cross-react strongly with an antibody raised against
the rat PD-1L (B-10), suggesting that the Torpedo
activity may also be accounted for by PDase-I
(data not shown). In conclusion, therefore, it is likely
that ecto-ApnAases do not represent a previously
undescribed group of enzymes but potentially impor-
tant activities of the alkaline phosphodiesterase-I/nu-
cleotide pyrophosphatase family.
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